Resistant Cancer

Drug	Drug Name	Drug Description
DB01005	Hydroxyurea	An antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip).

Drug	Drug Name	Target	Type
DB01005	Hydroxyurea	Ribonucleoside-diphosphate reductase large subunit	target
DB01005	Hydroxyurea	Solute carrier organic anion transporter family member 1A2	transporter
DB01005	Hydroxyurea	Solute carrier organic anion transporter family member 1B1	transporter
DB01005	Hydroxyurea	Solute carrier organic anion transporter family member 1B3	transporter
DB01005	Hydroxyurea	Urea transporter 2	transporter
DB01005	Hydroxyurea	Urea transporter 1	transporter
DB01005	Hydroxyurea	Solute carrier family 22 member 4	transporter
DB01005	Hydroxyurea	Solute carrier family 22 member 5	transporter
DB01005	Hydroxyurea	Serum albumin	carrier
DB01005	Hydroxyurea	Urease subunit alpha	enzyme

Drug	Drug Name	Phase	Status	Count
DB00531	Cyclophosphamide	1	Not Yet Recruiting	1
DB01073	Fludarabine	1	Not Yet Recruiting	1
DB11967	Binimetinib	1 / 2	Recruiting	1
DB08865	Crizotinib	1 / 2	Recruiting	1
DB12130	Lorlatinib	1 / 2	Recruiting	1
DB00062	Albumin human	2	Active Not Recruiting	1
DB00958	Carboplatin	2	Active Not Recruiting	1
DB00997	Doxorubicin	2	Active Not Recruiting	1
DB16047	Elraglusib	2	Active Not Recruiting	1
DB00441	Gemcitabine	2	Active Not Recruiting	1
DB00762	Irinotecan	2	Active Not Recruiting	1
DB01206	Lomustine	2	Active Not Recruiting	1
DB14123	Menthol	2	Active Not Recruiting	1
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB09078	Lenvatinib	Not Available	Recruiting	1